$4.50
0.6516.88%
After Hours: 4:00 PM EDT
Comments
Loading...
Biodexa Pharmaceuticals (BDRX) Forecast
NewsEarningsBiodexa Pharmaceuticals (BDRX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBiodexa Pharmaceuticals (NASDAQ:BDRX) Stock Quotes, Forecast and News Summary
Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Biodexa Pharmaceuticals (BDRX) stock?
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ:BDRX) through any online brokerage.
Who are Biodexa Pharmaceuticals (BDRX) competitors?
Other companies in Biodexa Pharmaceuticals’s space includes: Kezar Life Sciences (NASDAQ:KZR), bluebird bio (NASDAQ:BLUE), Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX) and Elicio Therapeutics (NASDAQ:ELTX).
What is the forecast, or price target, for Biodexa Pharmaceuticals (BDRX) stock?
Biodexa Pharmaceuticals has a consensus price target of $8.00.
What is the current price for Biodexa Pharmaceuticals (BDRX)?
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $4.5 last updated November 21, 2024 at 4:00 PM EST.
Does Biodexa Pharmaceuticals (BDRX) pay a dividend?
There are no upcoming dividends for Biodexa Pharmaceuticals.
When is Biodexa Pharmaceuticals (NASDAQ:BDRX) reporting earnings?
Biodexa Pharmaceuticals’s H1 earnings are confirmed for Tuesday, December 3, 2024.
Is Biodexa Pharmaceuticals (BDRX) going to split?
There is no upcoming split for Biodexa Pharmaceuticals.
What sector and industry does Biodexa Pharmaceuticals (BDRX) operate in?
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.